Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.7547
+0.0427 (6.00%)
At close: Feb 6, 2026, 4:00 PM EST
0.7460
-0.0087 (-1.15%)
After-hours: Feb 6, 2026, 7:59 PM EST
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $15.67 million as of February 6, 2026. Its market cap has decreased by -35.52% in one year.
Market Cap
15.67M
Enterprise Value
13.23M
1-Year Change
-35.52%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $15.67M, a decrease of -48.96%. That is a compound annual growth rate of -7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 15.70M | -2.48% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 18.04M |
| Klotho Neurosciences | 17.66M |
| Genenta Science | 17.15M |
| FibroBiologics | 16.74M |
| Pasithea Therapeutics | 16.74M |
| Quantum BioPharma | 16.02M |
| Iterum Therapeutics | 15.96M |
| Lunai Bioworks | 15.78M |